| COVID-19 |
1 |
1 |
| COVID-19 Treatment |
0 |
0.98 |
| COVID-19 Vaccine |
0 |
0.61 |
| Generics |
0 |
0.47 |
| Antidepressant drug |
0 |
0.99 |
| Washington |
0 |
0.41 |
| Minnesota |
0 |
0.27 |
| Pandemic |
0 |
0.27 |
| Depression |
0 |
0.22 |
| Selective Serotonin-Reuptake Inhibitors |
0 |
0.19 |
| Adherence |
0 |
0.14 |
| Adverse Effects |
0 |
0.14 |
| Antiviral Agents |
0 |
0.14 |
| Canada |
0 |
0.14 |
| Child |
0 |
0.14 |
| Clinician Health and Well-Being |
0 |
0.14 |
| Cytokines |
0 |
0.14 |
| Dizziness |
0 |
0.14 |
| Grant |
0 |
0.14 |
| Hospital |
0 |
0.14 |
| Insomnia |
0 |
0.14 |
| Metabolism |
0 |
0.14 |
| Monoclonal Antibody |
0 |
0.14 |
| Nausea |
0 |
0.14 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.14 |
| Outpatient Clinic |
0 |
0.14 |
| Peer Review |
0 |
0.14 |
| Preventive Screening |
0 |
0.14 |
| Receptors |
0 |
0.14 |
| Biologic Therapy |
0 |
0.12 |
| Patient Safety |
0 |
0.11 |
| HIV Infection |
0 |
0.08 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.05 |
| Health Care Reform |
0 |
0.05 |
| Influenza |
0 |
0.05 |
| Medical Life |
0 |
0.05 |
| Obsessive-Compulsive Disorder |
0 |
0.05 |
| Sleep Disorders |
0 |
0.05 |
| Vaccines |
0 |
0.05 |